August Moretti

2020

In 2020, August Moretti earned a total compensation of $632.8K as Chief Financial Officer at 4D Molecular Therapeutics, a 70% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$220,050
Salary$399,712
Other$13,000
Total$632,762

Moretti received $399.7K in salary, accounting for 63% of the total pay in 2020.

Moretti also received $220.1K in non-equity incentive plan and $13K in other compensation.

Rankings

In 2020, August Moretti's compensation ranked 10,321st out of 13,090 executives tracked by ExecPay. In other words, Moretti earned more than 21.2% of executives.

ClassificationRankingPercentile
All
10,321
out of 13,090
21st
Division
Manufacturing
4,419
out of 5,621
21st
Major group
Chemicals And Allied Products
1,825
out of 2,254
19th
Industry group
Drugs
1,597
out of 1,954
18th
Industry
Biological Products, Except Diagnostic Substances
361
out of 411
12th
Source: SEC filing on April 6, 2021.

Moretti's colleagues

We found two more compensation records of executives who worked with August Moretti at 4D Molecular Therapeutics in 2020.

2020

Robert Fishman

4D Molecular Therapeutics

Chief Medical Officer

2020

David Kirn

4D Molecular Therapeutics

Chief Executive Officer

News

You may also like